药品注册申请号:019183
申请类型:NDA (新药申请)
申请人:ABBVIE
申请人全名:ABBVIE INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 CARAFATE SUCRALFATE SUSPENSION;ORAL 1GM/10ML Yes Yes AB 1993/12/16 1993/12/16 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2023/05/12 SUPPL-21(补充) Approval Labeling STANDARD
2017/08/15 SUPPL-19(补充) Approval Labeling STANDARD
2016/06/06 SUPPL-18(补充) Approval Manufacturing (CMC) STANDARD
2013/03/04 SUPPL-16(补充) Approval Labeling STANDARD
2010/12/21 SUPPL-14(补充) Approval Labeling UNKNOWN
2007/04/26 SUPPL-11(补充) Approval Labeling STANDARD
2006/02/10 SUPPL-9(补充) Approval Manufacturing (CMC) STANDARD
2000/02/08 SUPPL-7(补充) Approval Manufacturing (CMC) STANDARD
1997/08/14 SUPPL-4(补充) Approval Manufacturing (CMC) STANDARD
1997/07/16 SUPPL-6(补充) Approval Manufacturing (CMC) STANDARD
1995/08/21 SUPPL-3(补充) Approval Manufacturing (CMC) STANDARD
1994/07/13 SUPPL-2(补充) Approval Labeling STANDARD
1994/04/11 SUPPL-1(补充) Approval Manufacturing (CMC) STANDARD
1993/12/16 ORIG-1(原始申请) Approval Type 3 - New Dosage Form STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:SUCRALFATE 剂型/给药途径:SUSPENSION;ORAL 规格:1GM/10ML 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
019183 001 NDA CARAFATE SUCRALFATE SUSPENSION;ORAL 1GM/10ML Prescription Yes Yes AB 1993/12/16 ABBVIE
209356 001 ANDA SUCRALFATE SUCRALFATE SUSPENSION;ORAL 1GM/10ML Prescription No No AB 2019/12/02 AMNEAL
211884 001 ANDA SUCRALFATE SUCRALFATE SUSPENSION;ORAL 1GM/10ML Prescription No No AB 2022/03/15 VISTAPHARM LLC
212913 001 ANDA SUCRALFATE SUCRALFATE SUSPENSION;ORAL 1GM/10ML Prescription No No AB 2022/09/12 MYLAN
213549 001 ANDA SUCRALFATE SUCRALFATE SUSPENSION;ORAL 1GM/10ML Prescription No No AB 2024/01/17 PD PARTNERS
216726 001 ANDA SUCRALFATE SUCRALFATE SUSPENSION;ORAL 1GM/10ML Prescription No No AB 2024/03/21 ABON PHARMS LLC
216474 001 ANDA SUCRALFATE SUCRALFATE SUSPENSION;ORAL 1GM/10ML Prescription No No AB 2024/05/21 STRIDES PHARMA
212769 001 ANDA SUCRALFATE SUCRALFATE SUSPENSION;ORAL 1GM/10ML Prescription No No AB 2024/07/23 HIKMA
217126 001 ANDA SUCRALFATE SUCRALFATE SUSPENSION;ORAL 1GM/10ML Prescription No No AB 2024/11/13 COSETTE
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database